Evidence map›Paper›PMID 37868344›Full record

ArticleValasan kanphaet Lao2021

A pilot study to investigate the risk of SARS-CoV-2 household transmission following hospital discharge of confirmed cases in Vientiane Capital, Lao PDR.

Mayfong Mayxay, Phimpha Paboriboune, Xaipasong Xaiyaphet, Khamfong Kunlaya, Manivanh Vongsouvath, Bountoy Sibounheuang, Audrey Dubot-Pérès, Andrew J H Simpson, Matthew T Robinson, Khamla Choumlivong and 10 more

Open access · greenAbstract read
In one paragraph

Article in Valasan kanphaet Lao, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 3 countries.

Mayfong MayxayLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
Phimpha PaboribouneCentre d'Infectiologie Lao-Christophe Mérieux (CILM), Ministry of Health, Lao PDR.
Xaipasong XaiyaphetLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
Khamfong KunlayaLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
Manivanh VongsouvathLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
Bountoy SibounheuangLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
Audrey Dubot-PérèsLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
Andrew J H SimpsonLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
Matthew T RobinsonLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
Khamla ChoumlivongSetthathirat Hospital, Vientiane capital, Lao PDR.
Vangnakhone DittaphongMittaphab Hospital, Vientiane capital, Lao PDR.
Manichanh ThongsanaMittaphab Hospital, Vientiane capital, Lao PDR.
Anouphet ChanthamavongMittaphab Hospital, Vientiane capital, Lao PDR.
Phetkim SayaseneMittaphab Hospital, Vientiane capital, Lao PDR.
Bandith SoumphonphakdyChildren Hospital, Vientiane capital, Lao PDR.
Khamphoua SoutthisombatDepartment of Health Care and Rehabilitation, Ministry of Health, Lao PDR.
Bouathep PhoumindrDepartment of Health Care and Rehabilitation, Ministry of Health, Lao PDR.
Rattanaxay PhetsouvanhDepartment of Communicable Disease Control, Ministry of Health, Lao PDR.
Phonepadith XangsayarathNational Center for Laboratory Epidemiology, Ministry of Health, Lao PDR.
Elizabeth A AshleyLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane Capital, Lao PDR.
University of Oxford · GBInstitut de Recherche pour le Développement · FRMinistry of Health · IDUniversity of Health Sciences

Funding

Wellcome Trust 106698
6 · The paper itself

Abstract

Background: Global guidelines from the World Health Organization on discharging patients diagnosed with COVID-19 changed in 2021 to a symptom-based rather than negative PCR-based approach. Studies have shown that shedding of viable virus continues for approximately eight days after symptom onset in most patients. In Vientiane, Laos, until now, patients diagnosed with asymptomatic or mild COVID-19 are hospitalised for 2 weeks and then, if they still test PCR positive for SARS-CoV-2, stay for a further week in a designated quarantine hotel before being discharged home. Objective: The aim of this pilot study was to investigate the risk of transmission of SARS-CoV-2 to household contacts of discharged patients who are still PCR-positive following 2-3 weeks quarantine in Vientiane, Lao PDR. Methods: Adult participants, who were resident in Vientiane Capital and who were about to be discharged from hospital (after 2 weeks hospitalisation), or from a quarantine hotel, following a further one-week quarantine, were screened to assess eligibility for the study. The household of each case was visited a maximum of 48 hours before or up to 24 hours after the participant was discharged and a nasopharyngeal swab was taken from all household members. Repeat nasopharyngeal swabs from cases and contacts were taken on day 7 and day 14 after discharge home of each case. Results: Between 20th May 2021 and 27th August 2021, 55 cases and 84 contacts in 27 households were enrolled in the study. The median [range] age of all 139 included participants was 26.5 years [3 months to 83 years] and 83 (60%) were female. By household, the median [range] number of cases and contacts were 1 [1-6] and 3 [1-13] respectively. At discharge home 32/48 (67%) cases tested positive for SARS-CoV-2. By day 7 11 of 47 cases (23%) still tested positive for SARS-CoV-2 by PCR and by day 14 this number was 2/24 (8%). No contacts tested positive during follow up and the numbers tested at the time of discharge of the case, 7 days later and 2 weeks later were 56, 57 and 37 respectively. Loss to follow up at day 7 and day 14 ranged from 15-50% (participants not at home at the time of visits). Conclusion: In this pilot study we found no evidence of onward transmission of SARS-CoV-2 to contacts of cases discharged home with a positive PCR result. This suggests the current discharge policy for mild to moderate COVID-19 case following 2 weeks in hospital in the Lao PDR is safe.

Indexed as

Hospital dischargeHousehold RiskLao PDRSARS-CoV-2

Identifiers

PMID37868344
PMCPMC7615233
OpenAlexW4387866139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.